Published in J Rheumatol on February 01, 1988
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis (2003) 2.03
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis (2000) 1.79
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis (2002) 1.76
Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis (2003) 1.26
Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis (2005) 1.21
The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int (2004) 1.04
Assessment of enthesitis in ankylosing spondylitis by power Doppler ultrasonography. Skeletal Radiol (2006) 1.03
The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol (2004) 1.00
Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol (2004) 1.00
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis (2004) 0.98
How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol (2014) 0.95
Treatment trials in ankylosing spondylitis: current and future considerations. Ann Rheum Dis (2002) 0.93
Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population. Rheumatol Int (2006) 0.91
ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis (2005) 0.90
Temporomandibular joint osseous morphology in a consecutive sample of ankylosing spondylitis patients. Ann Rheum Dis (1997) 0.89
Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review. Rheumatol Int (2005) 0.82
Large-scale open trials with etodolac (Lodine) in France: an assessment of safety. Rheumatol Int (1990) 0.82
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo. Ann Rheum Dis (2007) 0.81
[Pregnancy in patients with rheumatoid arthritis and inflammatory spondylarthropathies]. Z Rheumatol (2006) 0.80
Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis. Arthritis Res Ther (2012) 0.79
Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis. Rheumatol Int (2010) 0.78
Spondyloarthritides: evolving therapies. Arthritis Res Ther (2010) 0.77
Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco. BMC Musculoskelet Disord (2012) 0.75
Clinical Tools to Assess and Monitor Spondyloarthritis. Curr Rheumatol Rep (2015) 0.75
Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis. Rheumatol Int (2005) 0.75
Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity. Clin Rheumatol (1997) 0.75
Evaluation of the Turkish version of the Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Clin Rheumatol (2006) 0.75
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Regulated targeting of BAX to mitochondria. J Cell Biol (1998) 4.17
A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc Natl Acad Sci U S A (1996) 3.43
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum (2001) 3.37
Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests. Scand J Rheumatol Suppl (1987) 3.24
p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol (1997) 2.84
[Difficulties with immunofixation interpretation]. Ann Biol Clin (Paris) (2004) 2.56
Overnight orthokeratology. Optom Vis Sci (2000) 2.27
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 2.25
Sensitivity to change of various roentgenological severity scoring systems for osteoarthritis of the hip. Rev Rhum Engl Ed (1995) 2.13
Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol (1992) 1.93
Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem (1999) 1.92
Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2013) 1.76
E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol (1998) 1.75
Capacity of the clinical picture to characterize low back pain relieved by facet joint anesthesia. Proposed criteria to identify patients with painful facet joints. Spine (Phila Pa 1976) (1998) 1.71
Dynamics of subjective contour formation in the early visual cortex. Proc Natl Acad Sci U S A (2001) 1.69
Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med (1993) 1.67
Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis (1996) 1.64
Human breast carcinoma desmoplasia is PDGF initiated. Oncogene (2000) 1.59
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound. Scand J Rheumatol Suppl (1976) 1.58
Autocastration as a presenting sign of incipient schizophrenia. Psychiatr Serv (2001) 1.57
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA (2001) 1.57
High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage (1993) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Arthroscopic evaluation of chondropathy in osteoarthritis of the knee. J Rheumatol (1996) 1.55
Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum (2001) 1.52
Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) (1999) 1.51
Coexisting thyroid and parathyroid disease--are they related? Surgery (1983) 1.51
The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. Arthritis Rheum (2000) 1.51
Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis. Arthritis Rheum (1999) 1.47
Longitudinal study of associations between perceived health status and self reported diseases in the French Gazel cohort. J Epidemiol Community Health (2001) 1.46
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45
Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes. Am J Obstet Gynecol (1989) 1.39
Eosinophilia-myalgia linked with L-tryptophan. Lancet (1990) 1.39
[Local tolerance of subcutaneous heparin. Double-blind comparison of calcium and sodium heparins (author's transl)]. Sem Hop (1979) 1.39
Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage (1997) 1.38
Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med (1986) 1.38
Population genetics of the porB gene of Neisseria gonorrhoeae: different dynamics in different homology groups. Mol Biol Evol (2000) 1.36
Import and insertion of proteins into the mitochondrial outer membrane. Eur J Biochem (1995) 1.36
Future trends in mortality of French men from mesothelioma. Occup Environ Med (2000) 1.34
Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol (1999) 1.33
Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology (1995) 1.31
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest (2001) 1.29
Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci (1992) 1.28
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) (1999) 1.28
Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol (1996) 1.27
[Destructive arthropathies in chondrocalcinosis]. Rev Rhum Mal Osteoartic (1973) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Requirement for total hip arthroplasty: an outcome measure of hip osteoarthritis? J Rheumatol (1999) 1.17
Toll-like receptor alterations in myelodysplastic syndrome. Leukemia (2013) 1.16
Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol (1997) 1.15
The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res (1998) 1.15
The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood (1995) 1.15
Fiberoptic ductoscopy for patients with nipple discharge. Cancer (2000) 1.14
The DNA sequence and comparative analysis of human chromosome 10. Nature (2004) 1.14
Usefulness of criteria for spondyloarthropathies. Joint Bone Spine (2000) 1.14
A MADS box protein consensus binding site is necessary and sufficient for activation of the opaque-phase-specific gene OP4 of Candida albicans. J Bacteriol (1998) 1.14
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br Med J (Clin Res Ed) (1986) 1.13
Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes. Immunogenetics (1984) 1.11
Effect and mode of faction of chlorambucil in rheumatoid arthritis. The importance of the lymphoblast transformation test. Rev Eur Etud Clin Biol (1971) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Import and processing of hybrid proteins by mammalian mitochondria in vitro. J Biol Chem (1986) 1.10
Livistona extract inhibits angiogenesis and cancer growth. Oncol Rep (2001) 1.10
Tiopronin (N-[2-mercaptopropionyl] glycin) in rheumatoid arthritis. Arthritis Rheum (1982) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Sulfasalazine and ankylosing spondylitis. Ann Intern Med (1984) 1.09
Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation. J Leukoc Biol (1992) 1.08
BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ (2000) 1.08
The cloning and expression of a human creatine transporter. Biochem Biophys Res Commun (1994) 1.08
Tolerance to cooked egg in an egg allergic population. Allergy (2006) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells. Blood (1997) 1.07
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. Leukemia (2008) 1.06
Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis (2005) 1.05
Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer (2001) 1.05
Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education. Occup Environ Med (2007) 1.05
Panic disorder among Vietnamese refugees attending a psychiatric clinic: prevalence and subtypes. Gen Hosp Psychiatry (2001) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Retracted p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res (2001) 1.04
Letter: HL-A antigen W27--a genetic link between ankylosing spondylitis and Reiter's syndrome? N Engl J Med (1974) 1.04
The SFA system for assessing articular cartilage lesions at arthroscopy of the knee. Arthroscopy (1994) 1.04